Ser244
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.8.2
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser244  -  PRKD2 (human)

Site Information
SSSSSSAsSYTGRPI   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 1028300

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 ) , mutation of modification site ( 1 ) , phospho-antibody ( 1 ) , western blotting ( 1 )
Disease tissue studied:
gastric cancer ( 1 ) , gastric carcinoma ( 1 )
Relevant cell line - cell type - tissue:
293 (epithelial) ( 1 ) , AGS-B (gastric) ( 1 ) , Jurkat (T lymphocyte) ( 2 )

Upstream Regulation
Putative in vivo kinases:
CK1D (human) ( 1 ) , CK1E (human) ( 1 )
Kinases, in vitro:
CK1D (human) ( 1 ) , CK1E (human) ( 1 )
Treatments:
CKI-7 ( 1 ) , D4476 ( 1 ) , gastrin ( 1 ) , IC261 ( 1 ) , siRNA ( 1 )

Downstream Regulation
Effects of modification on PRKD2:
intracellular localization ( 1 ) , molecular association, regulation ( 1 )
Effects of modification on biological processes:
signaling pathway regulation ( 1 ) , transcription, induced ( 1 )
Inhibit interaction with:
14-3-3 eta (human) ( 1 ) , 14-3-3 eta (mouse) ( 1 ) , Exportin-1 (human) ( 1 )

References 

1

von Blume J, et al. (2007) Phosphorylation at Ser244 by CK1 determines nuclear localization and substrate targeting of PKD2. EMBO J 26, 4619-33
17962809   Curated Info

2

Possemato A (2007) CST Curation Set: 2927; Year: 2007; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS:p[ST]
Curated Info